Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JUNO | BMRN | ABVX | ||
| Company | Juno Therapeutics | Biomarin Pharmaceuticals | Abivax Sa ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 86.97 | 54.04 | 125.00 | ||
| High | 87.01 | 55.05 | 125.64 | ||
| Low | 86.90 | 53.56 | 120.05 | ||
| Latest | 86.96 | 54.09 | 121.99 | ||
| Change | +0.09 | -0.01 | -2.04 | ||
| % Change | +0.10% | -0.02% | -1.64% | ||
| Volume | 3,696,100 | 2,438,300 | 1,178,900 | ||
| 20-Day Average Volume | 4,145,455 | 2,229,305 | 947,860 | ||
| Previous Close | 86.87 | 54.10 | 124.03 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 86.09 | 53.13 | 118.60 | ||
| 20-Day Raw Stochastic | 97.77% | 59.05% | 68.98% | ||
| 20-Day Relative Strength | 73.72 | 50.18 | 53.08 | ||
| Weighted Alpha | +175.90 | -6.94 | +160.97 | ||
| Today's Opinion | N/A | 72% Sell | 72% Buy | ||
| Previous Opinion | N/A | 72% Sell | 72% Buy | ||
| Last Month's Opinion | N/A | 40% Sell | Hold | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.42% since 02/26/18 | +4.40% since 05/15/26 | +6.51% since 05/15/26 | ||
| Low | 86.60 on 02/27/18 | 49.26 on 05/18/26 | 109.93 on 05/19/26 | ||
| High | 87.01 on 03/05/18 | 55.05 on 05/22/26 | 126.41 on 05/21/26 | ||
| 1-Month | |||||
| %Chg | +1.57% since 02/05/18 | -0.11% since 04/22/26 | +5.17% since 04/22/26 | ||
| Low | 84.77 on 02/20/18 | 49.26 on 05/18/26 | 106.00 on 04/29/26 | ||
| High | 87.01 on 03/05/18 | 57.44 on 05/05/26 | 129.18 on 05/06/26 | ||
| 3-Month | |||||
| %Chg | +63.46% since 12/05/17 | -15.59% since 02/20/26 | -6.41% since 02/20/26 | ||
| Low | 42.29 on 12/19/17 | 49.26 on 05/18/26 | 100.15 on 03/30/26 | ||
| High | 87.01 on 03/05/18 | 66.28 on 02/24/26 | 132.92 on 02/23/26 | ||
| 6-Month | |||||
| %Chg | +103.75% since 09/05/17 | -1.10% since 11/21/25 | +2.41% since 11/21/25 | ||
| Low | 40.11 on 09/06/17 | 49.26 on 05/18/26 | 100.15 on 03/30/26 | ||
| High | 87.01 on 03/05/18 | 66.28 on 02/24/26 | 148.83 on 12/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,096,926 | 10,454,731 | 9,721,992 | ||
| Shares Outstanding, K | 116,110 | 193,284 | 79,695 | ||
| Annual Sales | 79,360,000 | 3,221,250,000 | 0 | ||
| Annual Net Income | -245,580,000 | 348,900,000 | -380,270,000 | ||
| Last Quarter Sales | 44,820,000 | 766,210,000 | 0 | ||
| Last Quarter Net Income | -118,130,000 | 105,530,000 | -90,870,000 | ||
| 60-Month Beta | 3.24 | 0.23 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 11/01/17 | 0.76 on 05/04/26 | -1.19 on 03/23/26 | ||
| Earnings Date | 03/07/18 | 08/03/26 | 06/01/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.65 | 0.00 | ||